ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications

被引:52
作者
Chibon, F
Mariani, O
Derré, J
Mairal, A
Coindre, JM
Guillou, L
Sastre, X
Pédeutour, F
Aurias, A
机构
[1] INSERM, Inst Curie, U509, F-75248 Paris 05, France
[2] Inst Bergonie, Dept Pathol, Bordeaux, France
[3] Univ Lausanne Hosp, Dept Pathol, Lausanne, Switzerland
[4] Inst Curie, Dept Pathol, Paris, France
[5] CHU Nice, Nice Sophia Antipolis Univ, Genet Lab, Nice, France
关键词
D O I
10.1002/gcc.20012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant fibrous histiocytomas (MFHs) are aggressive tumors without any definable line of differentiation. We recently demonstrated that about 20% of them are characterized by high-level amplifications of the 12q14-q15 chromosome region, associated with either 1p32 or 6q23 band amplification. This genetic finding, very similar to that in well-differentiated liposarcomas, strongly suggests that these tumors actually correspond to undifferentiated liposarcomas. It also suggests that the lack of differentiation could be the consequence of amplification of target genes localized in the 1p32 or 6q23 bands. We report here the characterization by array CGH of the 6q23 minimal region of amplification. Our findings demonstrate that amplification and overexpression of ASK1 (MAP3K5), a gene localized in the 6q23 band and encoding a mitogen-activated protein kinase kinase kinase of the JNK-MAPK signaling pathway, could inhibit the adipocytic differentiation process of the tumor cells. Treatment of a cell line with specific inhibitors of ASK1 protein resulted in the bypass of the differentiation block and induction of a strong adipocytic differentiation. These observations indicate that ASK1 is a target for new therapeutic management of these aggressive tumors. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 25 条
[1]   Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site [J].
Adams, M ;
Reginato, MJ ;
Shao, DL ;
Lazar, MA ;
Chatterjee, VK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :5128-5132
[2]   Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene [J].
Albertson, DG ;
Ylstra, B ;
Segraves, R ;
Collins, C ;
Dairkee, SH ;
Kowbel, D ;
Kuo, WL ;
Gray, JW ;
Pinkel, D .
NATURE GENETICS, 2000, 25 (02) :144-146
[3]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[4]   A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas [J].
Chibon, F ;
Mariani, O ;
Derré, J ;
Malinge, S ;
Coindre, JM ;
Guillou, L ;
Lagacé, W ;
Aurias, A .
CANCER GENETICS AND CYTOGENETICS, 2002, 139 (01) :24-29
[5]   Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay [J].
De Preter, K ;
Speleman, F ;
Combaret, V ;
Lunec, J ;
Laureys, G ;
Eussen, BHJ ;
Francotte, N ;
Board, J ;
Pearson, ADJ ;
De Paepe, A ;
Van Roy, N ;
Vandesompele, J .
MODERN PATHOLOGY, 2002, 15 (02) :159-166
[6]   Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma [J].
Demetri, GD ;
Fletcher, CDM ;
Mueller, E ;
Sarraf, P ;
Naujoks, R ;
Campbell, N ;
Spiegelman, BM ;
Singer, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3951-3956
[7]   Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances:: An analysis of a series of 27 leiomyosarcomas [J].
Derré, J ;
Lagacé, R ;
Nicolas, A ;
Mairal, A ;
Chibon, F ;
Coindre, JM ;
Terrier, P ;
Sastre, X ;
Aurias, A .
LABORATORY INVESTIGATION, 2001, 81 (02) :211-215
[8]  
Fritz B, 2002, CANCER RES, V62, P2993
[9]   Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction [J].
Gotoh, Y ;
Cooper, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) :17477-17482
[10]   A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor I complex in Jurkat T cells [J].
He, KL ;
Ting, AT .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (17) :6034-6045